• About us
    • History
    • Advantages
    • IPHAR company group
    • Board of directors
    • Scientific council
  • Investment projects
    • Preclinical stage
    • Clinical stage
    • Information for investors
  • Services
    • Drug development
    • Pharmaceutical technology
    • Pharmaceutical development
    • Preclinical trials
    • Pharmaceutical and
      pharmacokinetic analysis
    • Clinical trials
  • Video
  • Skolkovo Collective Use Center
  • Contacts
  • Job offerings
  • RURU
  • About us
    • History
    • Advantages
    • IPHAR company group
    • Board of directors
    • Scientific council
  • Investment projects
    • Preclinical stage
    • Clinical stage
    • Information for investors
  • Services
    • Drug development
    • Pharmaceutical technology
    • Pharmaceutical development
    • Preclinical trials
    • Pharmaceutical and
      pharmacokinetic analysis
    • Clinical trials
  • Video
  • Skolkovo Collective Use Center
  • Contacts
  • Job offerings
  • RURU

IPHAR (Innovative Pharmacology Research, LLC ) Skolkovo FASIE

IPHAR (Innovative Pharmacology Research, LLC )

  • About us
    • History
    • Advantages
    • IPHAR company group
    • Board of directors
    • Scientific council
  • Investment projects
    • Preclinical stage
    • Clinical stage
    • Information for investors
  • Services
    • Drug development
    • Pharmaceutical technology
    • Pharmaceutical development
    • Preclinical trials
    • Pharmaceutical and
      pharmacokinetic analysis
    • Clinical trials
  • Video
  • Skolkovo Collective Use Center
  • Contacts
  • Job offerings
  • RURU

День: 22.12.2017

Томичи разрабатывают противовоспалительное средство, не вызывающее язву желудка

22.12.2017No category

Разработчики томской фармкомпании “Ифар” работают над низкотоксичным противовоспалительным препаратом с принципиально новым механизмом действия.

Categories

  • No category
  • Exhibitions
December 2017
M T W T F S S
« Oct   Mar »
 123
45678910
11121314151617
18192021222324
25262728293031

© 2025 IPHAR (Innovative Pharmacology Research, LLC ) All Rights Reserved.